Atlas Trials

Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents

Clinical trial NCT00330343 · COMPLETED

Trial details

NCT number
NCT00330343
Sponsor
Johns Hopkins University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
PainNauseaPruritus
Start date
2004-05-01
Primary completion
2009-06-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.